Literature DB >> 6262238

Comparison of in vitro lymphocyte proliferations induced by cytomegalovirus-infected human fibroblasts and cell-free cytomegalovirus.

J Schirm, H W Roenhorst, T H The.   

Abstract

In vitro lymphocyte reactivity (LR) to cytomegalovirus (CMV)-infected human fetal fibroblasts (CMVFF) and cell-free CMV were measured by using lymphocytes from healthy donors. Lymphocytes from all seropositive donors were stimulated by CMVFF, whereas lymphocytes from negative donors were not. The optimal stimulator cell-to-lymphocyte ratio was in the range of 1:5 to 1:50, dependent on the virus dose used. LR to cell-free CMV was positive for 15 out of 18 seropositive donors and negative for 14 out of 16 seronegative donors. In most cases LR to CMVFF was considerably higher than LR to cell-free CMV. Within the CMV seropositive group there was no significant correlation between the LR to either CMVFF or cell-free CMV and the levels of antibodies to CMV early antigens or CMV late antigens. There was no strict correlation between LR to CMVFF and to cell-free CMV, especially not in tests with lymphocytes from two patients with CMV mononucleosis. Our data suggest that CMVFF and cell-free CMV are recognized (partly) by different subpopulations of CMV-specific memory lymphocytes. We conclude that the use of CMV-infected cells, in addition to cell-free CMV, in LR tests gives more reproducible and possibly also additional information about CMV-specific cellular immunity.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6262238      PMCID: PMC551360          DOI: 10.1128/iai.30.3.621-627.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  Use of cryopreserved virus-infected target cells in a lymphocytotoxicity 51Cr release microassay for cell-mediated immunity to cytomegalovirus.

Authors:  Y H Thong; S A Hensen; M M Vincent; D A Fuccillo; W A Stiles; J A Bellanti
Journal:  Infect Immun       Date:  1976-02       Impact factor: 3.441

Review 2.  Participation of lymphocytes in viral infections.

Authors:  E F Wheelock; S T Toy
Journal:  Adv Immunol       Date:  1973       Impact factor: 3.543

3.  Plaque assay of cytomegalovirus strains of human origin.

Authors:  B B Wentworth; L French
Journal:  Proc Soc Exp Biol Med       Date:  1970-11

Review 4.  The cytomegaloviruses: ubiquitous agents with protean clinical manifestations. I.

Authors:  T H Weller
Journal:  N Engl J Med       Date:  1971-07-22       Impact factor: 91.245

Review 5.  Interactions of antibodies, complement components and various cell types in immunity against viruses and pyogenic bacteria.

Authors:  A C Allison
Journal:  Transplant Rev       Date:  1974

6.  Antibody reactions to virus-specific early antigens (EA) in patients with cytomegalovirus (CMV) infection.

Authors:  T H The; G Klein; M M Langenhuysen
Journal:  Clin Exp Immunol       Date:  1974-01       Impact factor: 4.330

7.  Epidemiology of cytomegalovirus infection after transplantation and immunosuppression.

Authors:  M Fiala; J E Payne; T V Berne; T C Moore; W Henle; J Z Montgomerie; S N Chatterjee; L B Guze
Journal:  J Infect Dis       Date:  1975-10       Impact factor: 5.226

8.  Specific impairment of cell-mediated immunity in mothers of infants with congenital infection due to cytomegalovirus.

Authors:  M Rola-Pleszczynski; L D Frenkel; D A Fuccillo; S A Hensen; M M Vincent; D W Reynolds; S Stagno; J A Bellanti
Journal:  J Infect Dis       Date:  1977-03       Impact factor: 5.226

9.  Lymphocyte activation in subacute sclerosing panencephalitis virus and cytomegalovirus infections. In vitro stimulation in response to viral-infected cell lines.

Authors:  G B Thurman; A Ahmed; D M Strong; R C Knudsen; W R Grace; K W Sell
Journal:  J Exp Med       Date:  1973-10-01       Impact factor: 14.307

View more
  5 in total

1.  In vitro stimulation of lymphocytes by different strains of cytomegalovirus.

Authors:  L Gärtner; J A Wilhelm; R Czieschnek
Journal:  Med Microbiol Immunol       Date:  1982       Impact factor: 3.402

2.  Maintenance of cytomegalovirus (CMV) latency and host immune responses of long term renal allograft survivors. I. Prolonged suppression of in vitro lymphocyte responses against CMV infected fibroblasts related to previous secondary CMV infection.

Authors:  H W Roenhorst; J M Middeldorp; J M Beelen; J Schirm; A M Tegzess; T H The
Journal:  Clin Exp Immunol       Date:  1985-03       Impact factor: 4.330

3.  Cytomegalovirus (CMV): specific lymphokine production in congenital CMV infection.

Authors:  R C Gehrz; T E Leonard
Journal:  Clin Exp Immunol       Date:  1985-12       Impact factor: 4.330

4.  The cellular immune response to cell-associated and cell-free cytomegalovirus (CMV) antigens after primary CMV-infection in non-immunocompromised hosts: development and maintenance of CMV-latency and its influence on immunocompetence.

Authors:  H W Roenhorst; C G Kallenberg; T H The
Journal:  Clin Exp Immunol       Date:  1988-12       Impact factor: 4.330

5.  Effect of cyclosporine on the response of normal human lymphocytes to cytomegalovirus in vitro.

Authors:  P J Converse; A D Hess; P J Tutschka; G W Santos
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.